SCGBL Activators
SCGBL can initiate their action through various molecular interactions that ultimately lead to the protein's activation. Forskolin directly stimulates adenylate cyclase, leading to an increase in cyclic AMP (cAMP) within cells. The elevated cAMP levels enhance protein kinase A (PKA) activity, which in turn can phosphorylate SCGBL, leading to its activation. Similarly, Isoproterenol, a beta-adrenergic agonist, binds to beta receptors, resulting in adenylate cyclase activation and a rise in cAMP. This rise activates PKA, which then phosphorylates and activates SCGBL. PGE2, by interacting with its receptors, follows a similar pathway, causing an increase in cAMP and activating PKA, which then can activate SCGBL through phosphorylation.
IBMX works by inhibiting the breakdown of cAMP and cGMP, leading to their accumulation and the subsequent activation of PKA, which can activate SCGBL. Epinephrine and Salbutamol, through their action on adrenergic receptors, also result in increased cAMP production and PKA activation, leading to the phosphorylation and activation of SCGBL. Histamine, via H2 receptors, and dopamine, through D1-like receptors, both increase adenylate cyclase activity, thus raising cAMP levels and activating PKA, which can then target SCGBL for activation. Anagrelide, by inhibiting phosphodiesterases, Terbutaline, a β2-adrenergic agonist, and Rolipram, a phosphodiesterase 4 inhibitor, all result in increased cAMP levels, enhancing PKA activity and the subsequent phosphorylation and activation of SCGBL. Zaprinast, by inhibiting PDE5, indirectly raises cGMP levels, which can lead to an increase in cAMP through cross-talk mechanisms, thereby activating PKA and enabling the phosphorylation and activation of SCGBL.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that binds to beta receptors, leading to activation of adenylate cyclase and a subsequent rise in cAMP. This rise in cAMP activates PKA, which can then target and activate SCGBL as part of its downstream effects. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) interacts with its receptors, leading to an increase in intracellular cAMP levels, activating PKA. PKA activation can then lead to phosphorylation and activation of SCGBL. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
3-Isobutyl-1-methylxanthine (IBMX) is a nonspecific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to their accumulation. Higher cAMP levels can enhance PKA activity and potentially lead to the activation of SCGBL. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine engages adrenergic receptors, which can activate adenylate cyclase and increase cAMP production. Through the activation of PKA, epinephrine can contribute to the phosphorylation and activation of SCGBL. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $94.00 $141.00 | ||
Salbutamol is a selective β2-adrenergic receptor agonist that causes an increase in cAMP levels via adenylate cyclase activation. The cAMP acts on PKA, which may phosphorylate and activate SCGBL. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can bind to H2 receptors, which activate adenylate cyclase, leading to increased cAMP levels. This activation of PKA can subsequently phosphorylate and activate SCGBL. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine, through its action on D1-like dopamine receptors, can stimulate adenylate cyclase, raise cAMP levels, and activate PKA. PKA can then potentially activate SCGBL through phosphorylation. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Anagrelide increases cAMP levels by inhibiting phosphodiesterases. This can lead to activation of PKA, which could phosphorylate SCGBL, resulting in its activation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, leading to increased cAMP levels within the cell. This results in PKA activation, which can phosphorylate and activate SCGBL. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterases, particularly PDE5, resulting in increased cGMP levels, which can enhance cAMP levels through cross-talk. PKA, activated by cAMP, can then phosphorylate and activate SCGBL. | ||||||